Cover Image
市場調查報告書

全球肺部藥物遞輸系統市場:市場方案,市場規模,趨勢,預測

Global Pulmonary Drug Delivery Systems Market by Product - Global Scenario, Market Size, Outlook, Trend and Forecast, 2016-2025

出版商 Variant Market Research LLP 商品編碼 649275
出版日期 內容資訊 英文 101 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球肺部藥物遞輸系統市場:市場方案,市場規模,趨勢,預測 Global Pulmonary Drug Delivery Systems Market by Product - Global Scenario, Market Size, Outlook, Trend and Forecast, 2016-2025
出版日期: 2018年06月03日 內容資訊: 英文 101 Pages
簡介

本報告提供全球肺部藥物遞輸系統市場調查,提供市場概要,各產品類型·用途·流通管道·地區的市場趨勢,市場規模的變化與預測,市場佔有率,市場促進·阻礙因素以及市場機會分析,競爭情形,主要企業的簡介等全面性資訊。

第1章 簡介

第2章 摘要整理

  • 與前一年同期比較成長率的轉變及預測

第3章 市場概要

  • 市場趨勢,趨勢,預測,著眼點
  • 市場佔有率分析:企業的競爭模式
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會

第4章 全球肺部藥物遞輸系統市場:各產品類型

  • 市場概要
  • 乾粉吸入劑(DPI)
    • 單劑量型
    • 多回給藥型
  • 定量吸入器(MDI)
    • 手動式吸入器
    • 呼氣感應型吸入器
  • 噴霧器
    • 噴氣式噴霧器
    • 超音波式噴霧器
    • 篩孔式噴霧器

第5章 全球肺部藥物遞輸系統市場:各用途

  • 市場概要
  • 氣喘
  • 慢性阻塞性肺病
  • 囊腫纖維化
  • 其他

第6章 全球肺部藥物遞輸系統市場:各流通管道

  • 市場概要
  • 零售藥局
  • 院內藥局
  • 電子商務

第7章 全球肺部藥物遞輸系統市場:各地區

  • 市場概要
  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 其他
  • 亞太地區
    • 印度
    • 中國
    • 日本
    • 韓國
    • 其他
  • 其他地區
    • 南美
    • 中東
    • 非洲

第8章 企業簡介

  • AstraZeneca plc
  • Boehringer Ingelheim Gmbh
  • GlaxoSmithKline plc
  • Novartis AG
  • Koninklijke Philips N.V
  • 3M Company
  • Actelion Pharmaceuticals Ltd
  • Clement Clarke International
  • Briggs Healthcare
  • Aerogen
目錄

Global pulmonary drug delivery system market is estimated to reach $54.9 Billion by 2025 with CAGR of 6.2% between 2017 and 2025. Pulmonary drug delivery system is used to target diseases in the airways by delivering locally acting drugs directly to their site of action. Pulmonary route of drug delivery offer advantages such as small amount of drug, less adverse reaction and rapid onset of action. Increasing prevalence of chronic respiratory diseases like asthma, bronchitis is expected to grow the market of Pulmonary Drug Delivery Systems.

The major factors that fuel the market are; rising air pollution, increase in smoking, tuberculosis, chronic obstructive pulmonary disease, increasing demand for non-invasive methods, technological advancements such as smart inhaler, increasing geriatrics population. However, regulatory approvals and patent expiration of drugs may hamper the growth of global pulmonary drug delivery market. Moreover, rise in use of online marketing creates further opportunities for the market to sustain in the upcoming years.

The global pulmonary drug delivery systems market is segmented on the basis of product, application, and geography. On the basis of product, it is divided into metered dose inhalers (breath-actuated pressurized inhaler and manually-actuated pressurized inhaler), nebulizers (jet nebulizers, ultrasonic nebulizers, and vibrating mesh nebulizers), and dry powder inhalers (single dose inhalers and multi-dose inhalers). On the basis of distributor segment it is bifurcated into retail pharmacies, hospital pharmacies, and e-commerce. On the basis of application, the market is segmented into asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD), and others.

By geography, the global pulmonary drug delivery system market is segmented into North America, Europe, Asia-Pacific, and Rest of the world (RoW). The U.S., Canada, and Mexico are covered under North America wherein Europe covers UK, Germany, France, Italy, and others. Asia-Pacific covers China, India, Japan, South Korea, and others. Rest of the World covers South America, Middle East and Africa.

Key players in pulmonary drug delivery system market include: AstraZeneca plc, Boehringer Ingelheim Gmbh, GlaxoSmithKline plc, Novartis AG, Koninklijke Philips N.V., 3M Company, Actelion Pharmaceuticals Ltd, Clement Clarke International, Briggs Healthcare, and Aerogen.

The key takeaways from the report

  • The report will provide a detailed analysis of Global Pulmonary Drug Delivery System Market with respect to major segments such as product, application, distribution channel, and geography
  • The report will include the qualitative and quantitative analysis with market estimation over 2016-2025 and compound annual growth rate (CAGR) between 2017 and 2025
  • Comprehensive analysis of market dynamics including factors and opportunities will be provided in the report
  • An exhaustive regional analysis of Global Pulmonary Drug Delivery System Market from 2016 to 2025 has been included in the report
  • Profile of the key players in the Global Pulmonary Drug Delivery System Market will be provided, which include key financials, product & services, new developments and business strategies

Scope of the Global Pulmonary Drug Delivery System Market

Type Segments

  • Dry Powder Inhalers
    • Single dose inhaler
    • Multi dose inhaler
  • Metered dose inhalers
    • Manually-Actuated Pressurized Inhaler
    • Breath-Actuated Pressurized Inhaler

Application Segments

  • Asthma
  • Chronic obstructive pulmonary disease (COPD)
  • Cystic Fibrosis
  • Others

Distribution Channel Segments

  • Retail Pharmacies
  • Hospital Pharmacies
  • E-Commerce

Geographical Segments

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • RoW
    • South America
    • Middle East
    • Africa

Table of Contents

Chapter 1 Prefix

  • 1.1 Market Scope
  • 1.2 Report Description
  • 1.3 Research Methodology
    • 1.3.1 Primary Research
    • 1.3.2 Secondary Research
    • 1.3.3 In-house Data Modeling

Chapter 2 Executive Summary

  • 2.1 Global Pulmonary Drug Delivery System Market Year-on-Year Growth, 2017 - 2025 (%)

Chapter 3 Market Outline

  • 3.1 Market Inclination, Trend, Outlook and Viewpoint
  • 3.2 Market Share Analysis: Company's Competitive Scenario
  • 3.3 Market Dynamics
    • 3.3.1 Drivers
      • 3.3.1.1 Impact Analysis
    • 3.3.2 Restraints
      • 3.3.2.1 Impact Analysis
    • 3.3.3 Opportunities

Chapter 4 Global Pulmonary Drug Delivery System Market by Product: Market Size and Forecast, 2016 - 2025

  • 4.1 Overview
  • 4.2 Dry Powder Inhalers
    • 4.2.1 Current Trend and Analysis
    • 4.2.2 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 4.2.3 Market Size and Forecast by Region, 2016 - 2025 ($ Billion)
    • 4.2.4 Single Dose Inhalers
      • 4.2.4.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 4.2.5 Multi Dose Inhalers
      • 4.2.5.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
  • 4.3 Metered Dose Inhalers
    • 4.3.1 Current Trend and Analysis
    • 4.3.2 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 4.3.3 Market Size and Forecast by Region, 2016 - 2025 ($ Billion)
    • 4.3.4 Manually Actuated Pressurized Inhaler
      • 4.3.4.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 4.3.5 Breath Actuated Pressurized Inhaler
      • 4.3.5.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
  • 4.4 Nebulizers
    • 4.4.1 Current Trend and Analysis
    • 4.4.2 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 4.4.3 Market Size and Forecast by Region, 2016 - 2025 ($ Billion)
    • 4.4.4 Jet Nebulizers
      • 4.4.4.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 4.4.5 Ultrasonic Wave Nebulizers
      • 4.4.5.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 4.4.6 Vibrating Mesh Nebulizers
      • 4.4.6.1 Market Size and Forecast, 2016 - 2025 ($ Billion)

Chapter 5 Global Pulmonary Drug Delivery System Market by Application: Market Size and Forecast, 2016 - 2025

  • 5.1 Overview
  • 5.2 Asthma
    • 5.2.1 Current Trend and Analysis
    • 5.2.2 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 5.2.3 Market Size and Forecast by Region, 2016 - 2025 ($ Billion)
  • 5.3 Chronic Obstructive Pulmonary Disease
    • 5.3.1 Current Trend and Analysis
    • 5.3.2 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 5.3.3 Market Size and Forecast by Region, 2016 - 2025 ($ Billion)
  • 5.4 Cystic Fibrosis
    • 5.4.1 Current Trend and Analysis
    • 5.4.2 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 5.4.3 Market Size and Forecast by Region, 2016 - 2025 ($ Billion)
  • 5.5 Others
    • 5.5.1 Current Trend and Analysis
    • 5.5.2 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 5.5.3 Market Size and Forecast by Region, 2016 - 2025 ($ Billion)

Chapter 6 Global Pulmonary Drug Delivery System Market by Distribution Channel: Market Size and Forecast, 2016 - 2025

  • 6.1 Overview
  • 6.2 Retail Pharmacies
    • 6.2.1 Current Trend and Analysis
    • 6.2.2 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 6.2.3 Market Size and Forecast by Region, 2016 - 2025 ($ Billion)
  • 6.3 Hospital Pharmacies
    • 6.3.1 Current Trend and Analysis
    • 6.3.2 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 6.3.3 Market Size and Forecast by Region, 2016 - 2025 ($ Billion)
  • 6.4 E-Commerce
    • 6.4.1 Current Trend and Analysis
    • 6.4.2 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 6.4.3 Market Size and Forecast by Region, 2016 - 2025 ($ Billion)

Chapter 7 Global Pulmonary Drug Delivery System Market by Geography: Market Size and Forecast, 2016 - 2025

  • 7.1 Overview
    • 7.1.1 Global Pulmonary Drug Delivery System Market Year-on-Year Growth, by regions 2017 - 2025 (%)
  • 7.2 North America
    • 7.2.1 Current Trend and Analysis
    • 7.2.2 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 7.2.3 U.S.
      • 7.2.3.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 7.2.4 Canada
      • 7.2.4.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 7.2.5 Mexico
      • 7.2.5.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
  • 7.3 Europe
    • 7.3.1 Current Trend and Analysis
    • 7.3.2 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 7.3.3 UK
      • 7.3.3.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 7.3.4 Germany
      • 7.3.4.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 7.3.5 France
      • 7.3.5.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 7.3.6 Italy
      • 7.3.6.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 7.3.7 Rest of Europe
      • 7.3.7.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
  • 7.4 Asia-Pacific
    • 7.4.1 Current Trend and Analysis
    • 7.4.2 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 7.4.3 India
      • 7.4.3.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 7.4.4 China
      • 7.4.4.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 7.4.5 Japan
      • 7.4.5.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 7.4.6 South Korea
      • 7.4.6.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 7.4.7 Rest of Asia-Pacific
      • 7.4.7.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
  • 7.5 RoW
    • 7.5.1 Current Trend and Analysis
    • 7.5.2 Market Size and Forecast
    • 7.5.3 South America
      • 7.5.3.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 7.5.4 Middle East
      • 7.5.4.1 Market Size and Forecast, 2016 - 2025 ($ Billion)
    • 7.5.5 Africa
      • 7.5.5.1 Market Size and Forecast, 2016 - 2025 ($ Billion)

Chapter 8 Company Profiles

  • 8.1 AstraZeneca plc
  • 8.2 Boehringer Ingelheim Gmbh
  • 8.3 GlaxoSmithKline plc
  • 8.4 Novartis AG
  • 8.5 Koninklijke Philips N.V
  • 8.6 3M Company
  • 8.7 Actelion Pharmaceuticals Ltd
  • 8.8 Clement Clarke International
  • 8.9 Briggs Healthcare
  • 8.10 Aerogen
Back to Top